| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|
Unspecified oral dosage form, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|